CYTEK BIOSCIENCES INC (CTKB)
US23285D1090 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to CTKB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.26. This target is 27.89% above the current price.
CTKB was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CTKB.
In the previous month the buy percentage consensus was at a similar level.
CTKB was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-05-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-12-14 | Stephens & Co. | Initiate | Overweight |
| 2023-11-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-07-19 | Raymond James | Initiate | Market Perform |
| 2023-05-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-10 | Goldman Sachs | Maintains | Buy |
| 2023-03-07 | Piper Sandler | Maintains | Overweight |
| 2023-03-02 | Goldman Sachs | Maintains | Buy |
| 2023-03-02 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-18 | Piper Sandler | Maintains | Overweight |
| 2022-08-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-11 | Goldman Sachs | Maintains | Buy |
| 2022-07-14 | Goldman Sachs | Maintains | Buy |
| 2022-05-16 | Piper Sandler | Maintains | Overweight |
| 2022-05-13 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-12 | Goldman Sachs | Maintains | Buy |
| 2022-04-13 | Goldman Sachs | Maintains | Buy |
| 2022-02-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-08-17 | Cowen & Co. | Initiate | Outperform |
| 2021-08-17 | Goldman Sachs | Initiate | Buy |
| 2021-08-17 | Morgan Stanley | Initiate | Equal-Weight |
| 2021-08-17 | Piper Sandler | Initiate | Overweight |